CD79α expression in acute myeloid leukemia: High frequency of expression in acute promyelocytic leukemia

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1105-1110

  Arber, Daniel A ^a   Jenkins, Kay A ^a   Slovak, Marilyn L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; LYMPHOCYTE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CHROMOSOME 15Q; CHROMOSOME 17Q; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ANTIGENS, CD; ANTIGENS, CD79; ANTIGENS, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; RECEPTORS, ANTIGEN, B-CELL;

EID: 0029794267     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Sakaguchi N, Kashiwamura S, Kimoto M, Thalmann P, Melchers F: B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. EMBO J 1988, 7:3457-3464
2. van Noesel CJM, Borst J, de Vries EFR, van Lier RAW: Identification of two distinct phosphoproteins as components of the human B cell antigen receptor complex. Eur J Immunol 1990, 20:2789-2793
3. van Noesel CJM, van Lier RAW, Cordell JL, Tse AGD, van Schijndel GMW, de Vries EFR, Mason DY, Borst J: The membrane IgM-associated heterodimer on human B cells is a newly defined B cell antigen that contains the protein product of the mb-1 gene. J Immunol 1991, 146:3881-3888
4. van Noesel CJM, Brouns GS, van Schijndel GMW, Bende RJ, Mason DY, Borst J, van Lier RAW: Comparison of human B cell antigen receptor complexes: membrane-expressed forms of immunoglobulin (Ig)M, IgD, and IgG are associated with structurally related heterodimers. J Exp Med 1992, 175:1511-1519
5. Yu L, Chang TW: Human mb-1 gene: complete cDNA sequence and its expression in B cells bearing membrane Ig of various isotypes. J Immunol 1992, 148:633-637
6. Brouns GS, de Vries E, van Noesel CJM, Mason DY, van Lier RAW, Borst J: The structure of the μ/pseudo light chain complex on human pre-B cells is consistent with a function in signal transduction. Eur J Immunol 1993, 23:1088-1097
7. Mason DY, Cordell JL, Brown MH, Borst J, Jones M, Pulford K, Jaffe E, Ralfkiaer E, Dallenbach F, Stein H, Pileri S, Gatter KC: CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 1995, 86:1453-1459
8. Mason DY, Cordell JL, Tse AGD, van Dongen JJM, van Noesel CJM, Micklem K, Pulford KAF, Valensi F, Comans-Bitter WM, Borst J, Gatter KC: The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol 1991, 147:2474-2482
9. Mason DY, van Noesel CJM, Cordell JL, Comans-Bitter WM, Micklem K, Tse AGD, van Lier RAW, van Dongen JJM: The B29, and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol 1992, 22:2753-2756
10. Verschuren MCM, Comans-Bitter WM, Kapteijn CAC, Mason DY, Brouns GS, Borst J, Drexler HG, van Dongen JJM: Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia 1993, 7:1939-1947
11. Buccheri V, Mihaljevic B, Matutes E, Dyer MJS, Mason DY, Catovsky D: mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood 1993, 82:853-857
12. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med 1985, 103:626-629
13. Bennett JM, Catovsky D, Daniel M, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0). Br J Haematol 1991, 78:325-329
14. Sheibani K, Tubbs RR: Enzyme immunohistochemistry: technical aspects. Semin Diagn Pathol 1984, 1:235-250
15. Battifora H, Alsabeh R, Jenkins KA, Gown A: Epitope retrieval (unmasking) in immunohistochemistry. Adv Pathol Lab Med 1995, 8:101-118
16. ISCN: An International System for Human Cytogenetic Nomenclature. Edited by F Mitelman. Basel, S Karger, 1995
17. Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB: Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 1992, 80:582-586
18. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH: The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia 1994, 8:1108-1112
19. Reading CL, Estey EH, Huh YO, Claxton DF, Sanchez G, Terstappen LWMM, O'Brien MC, Baron S, Deisseroth AB: Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 1993, 81:3083-3090
20. + acute non-lymphocytic leukemia: evidence for an early multipotential progenitor. Leuk Res 1990, 14:23-26
21. Kita K, Miwa H, Nakase K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Kamada N, Nasu K, Uchino H: Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993, 81:2399-2405
22. Rovelli A, Biondi A, Rajnoldi AC, Conter V, Giudici G, Jankovic M, Locasciulli A, Rizzari C, Romitti L, Rossi MR, Schiró R, Tosi S, Uderzo C, Masera G: Microgranular variant of acute promyelocytic leukemia in children. J Clin Oncol 1992, 10:1413-1418
23. Paietta E, Wiernik PH, Andersen J, Bennett J, Yunis J: Acute myeloid leukemia M4 with inv(16) (p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993, 82:2595
24. Adriaansen HJ, te Boekhorst PAW, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJM: Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 1993, 81:3043-3051
25. Engel P, Wagner N, Tedder TF: CD79 workshop report: leucocyte typing V. White Cell Differentiation Antigens. Edited by SF Schlossman, L Boumsell, W Gilks, JM Harlan, T Kishimoto, C Morimoto, J Ritz, S Shaw, R Silverstein, T Springer, TF Tedder, RF Todd. Oxford, Oxford University Press, 1995, pp 667-670
26. Kita K, Nakase K, Miwa H, Masahiro M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992, 80:470-477
27. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Pelicci PG: Acute promyelocytic leukemia: from genetics to treatment. Blood 1994, 83:10-25
28. Hiorns LR, Min T, Swansbury GJ, Zelent A, Dyer MJS, Catovsky D: Interstitial insertion of retinoic acid receptor-α gene in acute promyelocytic leukemia with normal chromosomes 15 and 17. Blood 1994, 83:2946-2951
29. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pelicci PG: Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes. Blood 1995, 85:1169-1174
30. Chang K, Stass SA, Chu D, Deaven LL, Trujillo JM, Freireich EJ: Characterization of a fusion cDNA (RARA/ myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol 1992, 12:800-810
31. Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F, Biondi A, Grignani F, Pelicci PG: Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad USA 1992, 89:4840-4844